

BioNTech (NASDAQ:BNTX) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of BioNTech (NASDAQ:BNTX) through any online brokerage.
Other companies in BioNTech’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
BioNTech has a consensus price target of $125.88.
The stock price for BioNTech (NASDAQ: BNTX) is $81 last updated November 20, 2026 at 7:19 PM EST.
There are no upcoming dividends for BioNTech.
BioNTech does not have any upcoming earnings scheduled.
There is no upcoming split for BioNTech.
BioNTech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several...